SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Jubilant Pharmova Approves ₹800 Crore NCD Issue

The board approved issuing up to ₹800 crore of rupee-denominated non-convertible debentures through private placement, according to a regulatory filing.

JUBLPHARMA

According to a regulatory filing, the board approved the issue of up to 80,000 fully paid-up, rupee-denominated, sec…